Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular matrix (ECM) of human skin is a complex, three-dimensional network of macromolecules that provides essential structural support and biochemical signaling to the dermis and epidermis (StatPearls, 2023). It is primarily composed of fibrous proteins, most notably Type I and Type III collagen, which provide tensile strength, and elastin, which allows the skin to return to its original shape after stretching (NCBI, 2021). The ECM also contains a ground substance of glycosaminoglycans, such as hyaluronic acid, and proteoglycans like decorin, which are vital for maintaining tissue hydration and regulating the bioavailability of growth factors (PubMed, 2019). This matrix is not a static scaffold but a dynamic environment where components are constantly remodeled by enzymes such as matrix metalloproteinases (MMPs) and their inhibitors (UniProt, 2024). Dysregulation of skin ECM structural components is central to the pathology of photoaging, characterized by collagen fragmentation and solar elastosis, as well as genetic disorders like Ehlers-Danlos syndrome (NIH, 2022). Therapeutic interventions often target the ECM by using retinoids to stimulate collagen synthesis or using exogenous fillers and enzymes to modify matrix composition for aesthetic or medical purposes (Journal of Investigative Dermatology, 2020).
Stimulation of fibroblast activity and collagen synthesis via nuclear receptor signaling; enzymatic hydrolysis of collagen fibers; physical supplementation of glycosaminoglycans to restore volume.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular matrix structural components in human skin (ECM).